These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 14517416)

  • 1. Peroxovanadium compounds as inhibitors of angiogenesis.
    Doillon CJ; Faure RL; Posner BI; Savard PE
    Angiogenesis; 1999; 3(4):361-9. PubMed ID: 14517416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrest at the G2/M transition of the cell cycle by protein-tyrosine phosphatase inhibition: studies on a neuronal and a glial cell line.
    Faure R; Vincent M; Dufour M; Shaver A; Posner BI
    J Cell Biochem; 1995 Nov; 59(3):389-401. PubMed ID: 8567756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
    Band CJ; Posner BI; Dumas V; Contreres JO
    Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of JNK activation and MKP-1 expression by peroxovanadium complexes.
    Rumora L; Shaver A; Zanic-Grubisic T; Maysinger D
    Neurochem Int; 2001 Apr; 38(4):341-7. PubMed ID: 11137629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of MAPK by potassium bisperoxo(1,10-phenanthroline)oxovanadate (V).
    Cerovac Z; Ban J; Morinville A; Yaccato K; Shaver A; Maysinger D
    Neurochem Int; 1999 Apr; 34(4):337-44. PubMed ID: 10372920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms involved in the antiproliferative action of protein tyrosine phosphatase inhibitor potassium bisperoxo(1,10-phenanthroline)oxovanadate.
    Ban J; Maysinger D; Kovac V; Galetić I; Matulić M; Hadzija M; Uzarević B
    Life Sci; 2000 Dec; 68(2):165-75. PubMed ID: 11191635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin receptor kinase-associated phosphotyrosine phosphatases in hepatic endosomes: assessing the role of phosphotyrosine phosphatase-1B.
    Li C; Baquiran G; Gu F; Tremblay ML; Fazel A; Bergeron JJ; Posner BI
    Endocrinology; 2006 Feb; 147(2):912-8. PubMed ID: 16269466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisperoxovanadium complex promotes dopamine exocytosis in PC12 cells.
    Bieger S; Morinville A; Maysinger D
    Neurochem Int; 2002 Apr; 40(4):307-14. PubMed ID: 11792460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis.
    Bevan AP; Drake PG; Yale JF; Shaver A; Posner BI
    Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):49-58. PubMed ID: 8927047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of interferon-gamma-induced macrophage activation by phosphotyrosine phosphatases inhibition. Effect on murine Leishmaniasis progression.
    Olivier M; Romero-Gallo BJ; Matte C; Blanchette J; Posner BI; Tremblay MJ; Faure R
    J Biol Chem; 1998 May; 273(22):13944-9. PubMed ID: 9593743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for tyrosine phosphorylation in both activation and inhibition of the insulin receptor tyrosine kinase in vivo.
    Drake PG; Bevan AP; Burgess JW; Bergeron JJ; Posner BI
    Endocrinology; 1996 Nov; 137(11):4960-8. PubMed ID: 8895369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein tyrosine phosphatase inhibition reduces degeneration of dopaminergic substantia nigra neurons and projections in 6-OHDA treated adult rats.
    Yang P; Dankowski A; Hagg T
    Eur J Neurosci; 2007 Mar; 25(5):1332-40. PubMed ID: 17425559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition Effects of Some Bioactive Peroxovanadium Complexes on the Tyrosine Phosphatase.
    Zhou XW; Chen Z; Chen QX; Ye JL; Huang PQ; Wu QY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2000; 32(2):133-138. PubMed ID: 12098789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo insulin mimetic effects of pV compounds: role for tissue targeting in determining potency.
    Bevan AP; Burgess JW; Yale JF; Drake PG; Lachance D; Baquiran G; Shaver A; Posner BI
    Am J Physiol; 1995 Jan; 268(1 Pt 1):E60-6. PubMed ID: 7840184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxovanadium-mediated protection against murine leishmaniasis: role of the modulation of nitric oxide.
    Matte C; Marquis JF; Blanchette J; Gros P; Faure R; Posner BI; Olivier M
    Eur J Immunol; 2000 Sep; 30(9):2555-64. PubMed ID: 11009089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of dipotassium bisperoxo (picolinato) oxovanadate V for the treatment of pediatric low-grade gliomas.
    Ajeawung NF; Faure R; Jones C; Kamnasaran D
    Future Oncol; 2013 Aug; 9(8):1215-29. PubMed ID: 23902250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of protein tyrosine phosphatases in the regulation of interferon-{gamma}-induced macrophage nitric oxide generation: implication of ERK pathway and AP-1 activation.
    Blanchette J; Pouliot P; Olivier M
    J Leukoc Biol; 2007 Mar; 81(3):835-44. PubMed ID: 17170076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potassium bisperoxo (1,10-phenanthroline) oxovanadate suppresses proliferation of hippocampal neuronal cell lines by increasing DNA methyltransferases.
    Tian XL; Jiang SY; Zhang XL; Yang J; Cui JH; Liu XL; Gong KR; Yan SC; Zhang CY; Shao G
    Neural Regen Res; 2019 May; 14(5):826-833. PubMed ID: 30688268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of the ICAM-1 gene transcription by the peroxovanadium compound [bpV(Pic)] involves STAT-1 but not NF-kappa B activation in 293 cells.
    Audette M; Larouche L; Lussier I; Fugère N
    Eur J Biochem; 2001 Mar; 268(6):1828-36. PubMed ID: 11248703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peroxovanadium compound stimulates muscle glucose transport as powerfully as insulin and contractions combined.
    Nolte LA; Han DH; Hansen PA; Hucker KA; Holloszy JO
    Diabetes; 2003 Aug; 52(8):1918-25. PubMed ID: 12882906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.